DRD1A Receptor Therapy
“Composition and Endogenous Production of siRNA and miRNA Targeting mRNA of Checkpoint Protein Precursors”
US Patent Application Number 16/419,874
Filed May 22, 2019
“Compositions and Methods for Regulating Production of a Precursor Protein”
US Patent Application Number 17/105,967
Filed Nov 27, 2020
“Neuroreceptor Compositions and Methods Of Use”
US Patent Application Number 17/190,322
Filed March 2, 2021